PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Neurology

• Publication date

  2003-03-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/01.WNL.0000049930.93113.20PMID 12629228
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Validation of PET..Acquired Input Functions for CardiacStudies

  2006cited by this paper
• Low incidence of abnormal 18FDG-PET in children with new-onset partial epilepsy: A prospective study

  2002cited by this paper
• Localizing value of α-methyl-L-tryptophan PET in intractable epilepsy of neocortical origin

  2001cited by this paper
• Liquid chromatography-tandem mass spectrometry identification of metabolites of two 5-HT1A antagonists, N-[2-[4-(2-methoxylphenyl)piperazino]ethyl]-N-(2-pyridyl) trans- and cis-4-fluorocyclohexanecarboxamide, produced by human and rat hepatocytes.

  2001cited by this paper
• Comparative study of hippocampal neuronal loss and in vivo binding of 5-HT1a receptors in the KA model of limbic epilepsy in the rat.

  2001cited by this paper
• Volumetric measurements of subcortical nuclei in patients with temporal lobe epilepsy

  2001cited by this paper
• Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors.

  2000cited by this paper
• α[C-11]Methyl-l-Tryptophan PET Maps Brain Serotonin Synthesis and Kynurenine Pathway Metabolism

  2000cited by this paper
• Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine.

  2000cited by this paper
• Central 5-HT(1A) receptors: regional distribution and functional characteristics.

  2000cited by this paper
• Serotonin type-1A receptor imaging in depression.

  2000cited by this paper
• PET evaluation of [(18)F]FCWAY, an analog of the 5-HT(1A) receptor antagonist, WAY-100635.

  2000cited by this paper
• A review of central 5-HT receptors and their function.

  1999cited by this paper
• Development of fluorine-18-labeled 5-HT1A antagonists.

  1999cited by this paper
• Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites.

  1999cited by this paper
• Lasting Increase in Serotonin 5‐HT1A but Not 5‐HT4 Receptor Subtypes in the Kindled Rat Dentate Gyrus: Dissociation from Local Presynaptic Effects

  1998cited by this paper
• Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats.

  1998cited by this paper
• Extratemporal atrophy in patients with complex partial seizures of left temporal origin

  1998cited by this paper
• Endogenous serotonin inhibits epileptiform activity in rat hippocampal CA1 neurons via 5-hydroxytryptamine1A receptor activation.

  1998cited by this paper
• Imaging epileptogenic tubers in children with tuberous sclerosis complex usingα‐[11C]Methyl‐L‐tryptophan positron emission tomography

  1998cited by this paper
• Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: dose response relationships.

  1997cited by this paper
• Serotonin inhibits epileptiform discharge by activation of 5-HT1A receptors in CA1 pyramidal neurons.

  1997cited by this paper
• 11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy

  1997cited by this paper
• Central benzodiazepine receptor autoradiography in hippocampal sclerosis

  1997cited by this paper
• The Human Hippocampus: Functional Anatomy, Vascularization and Serial Sections with MRI

  1997cited by this paper
• Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635.

  1997cited by this paper
• Abnormalities in 5-HT1A and 5-HT1B receptor binding in severe-seizure genetically epilepsy-prone rats (GEPR-9s).

  1996cited by this paper
• Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11 C]WAY-100635.

  1996cited by this paper
• Stimulation of 5‐HT1A receptors in the dorsal hippocampus and inhibition of limbic seizures induced by kainic acid in rats

  1996cited by this paper
• Lack of 5-hydroxytryptamine1A-mediated inhibition of adenylyl cyclase in dorsal raphe of male and female rats.

  1996cited by this paper
• Effect of Valproate on Cerebral Metabolism and Blood Flow: An 18F‐2‐Deoxyglusose and 15O Water Positron Emission Tomography Study

  1996cited by this paper
• Inhibition of epileptiform activity by serotonin in rat CA1 neurons.

  1995cited by this paper
• Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist.

  1995cited by this paper
• The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain.

  1995cited by this paper
• First delineation of 5-HT1A receptors in human brain with PET and [11C]WAY-100635.

  1995cited by this paper
• Cromakalim- and RP 49356-induced 42K+ and 86Rb+ efflux in rat myometrium.

  1995cited by this paper
• 5-HT1A receptor linked to inward-rectifying potassium current in hippocampal CA3 pyramidal cells.

  1994cited by this paper
• Intra-hippocampal injection of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) inhibits partial and generalized seizures induced by kindling stimulation in cats.

  1993cited by this paper
• Autoradiographic analysis of serotonin receptors and transporter in kindled rat brain.

  1993cited by this paper
• Repeated treatment with electroconvulsive shock increases numbers of serotonin1A receptors in the rat hippocampus

  1993cited by this paper
• Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats.

  1992cited by this paper
• Regional Effects of Sodium Valproate on Extracellular Concentrations of 5‐Hydroxytryptamine, Dopamine, and Their Metabolites in the Rat Brain: An In Vivo Microdialysis Study

  1992cited by this paper
• Role of serotonin receptor subtype in seizures kindled from the feline hippocampus.

  1992cited by this paper
• The effects of serotonergic compounds on evoked responses in the dentate gyrus and CA1 region of the hippocampal formation of the rat.

  1991cited by this paper
• 5-Hydroxytryptamine hyperpolarizes CA3 hippocampal pyramidal cells through an increase in potassium conductance.

  1991cited by this paper
• Levels of biogenic amines, their metabolites, and tyrosine hydroxylase activity in the human epileptic temporal cortex

  1990cited by this paper
• Validation of PET-acquired input functions for cardiac studies.

  1988cited by this paper
• Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro.

  1987cited by this paper
• Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis.

  1983cited by this paper
• Alternative formula for glucose utilization using labeled deoxyglucose.

  1982cited by this paper
• Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method

  1979cited by this paper
• Anticonvulsant compounds and 5-hydroxytryptamine in rat brain.

  1957cited by this paper
• Journal of Cerebral Blood Flow and Metabolism Comparison of Bolus and Infusion Methods for Receptor Quantitation: Application to E8p]cyclofoxy and Positron Emission Tomography Cyclofoxy Infusion for Opiate Receptor Quant/tat/on Theory Compartment Models for Receptor-binding Radiotracers

  year unknowncited by this paper

• CBD and the 5-HT1A receptor: A medicinal and pharmacological review.

  2025cites this paper
• Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression.

  2025cites this paper
• Quantification of 5-HT1a receptors in temporal lobe epilepsy with PET and [18F]FCWAY: Effect of modeling methods on group discrimination.

  2025cites this paper
• Effects and mechanisms of anterior thalamus nucleus deep brain stimulation for epilepsy: a scoping review of preclinical studies.

  2024cites this paper
• Positron Emission Tomography (PET) in presurgical planning of anterior temporal lobectomy: A systematic review of efficacy and limitations.

  2024cites this paper
• Mood disorders in adults with epilepsy: a review of unrecognized facts and common misconceptions

  2024cites this paper
• Epilepsy is more than a simple seizure disorder: Causal relationships between epilepsy and its comorbidities.

  2023cites this paper
• 5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk?

  2023cites this paper
• Effects of the suppression of 5-HT1A receptors in the left, right, or bilateral basolateral amygdala on memory consolidation in chronic stress in male rats

  2023cites this paper
• The association between 5-HT1A binding and temporal lobe epilepsy: A meta-analysis of molecular imaging studies.

  2023cites this paper
• Sudden unexpected death in epilepsy: Respiratory mechanisms.

  2022cites this paper
• The diverse role of the raphe 5-HTergic systems in epilepsy

  2022cites this paper
• Urinary Neurotransmitter Patterns Are Altered in Canine Epilepsy

  2022cites this paper
• Augmented impulsive behavior in febrile seizure-induced mice

  2022cites this paper
• Positron Emission Tomography (PET) Imaging Tracers for Serotonin Receptors.

  2022cites this paper
• Radiotracers for the Central Serotoninergic System

  2022cites this paper
• High resolution and high sensitivity PET for quantitative molecular imaging of the monoaminergic nuclei: A GATE simulation study.

  2022cites this paper
• Decreased hippocampal serotonin 5HT1A expression in mesial temporal lobe of epilepsy patients.

  2022cites this paper
• Endocannabinoid-serotonin systems interaction in health and disease.

  2021cites this paper
• Genetic Factors Underlying Sudden Infant Death Syndrome

  2021cites this paper
• Multipronged Attack of Stem Cell Therapy in Treating the Neurological and Neuropsychiatric Symptoms of Epilepsy

  2021cites this paper
• Identification of clinically relevant biomarkers of epileptogenesis — a strategic roadmap

  2021cites this paper
• Do Psychotropic Drugs Cause Epileptic Seizures? A Review of the Available Evidence.

  2021cites this paper
• Medullary Serotonergic Binding Deficits and Hippocampal Abnormalities in Sudden Infant Death Syndrome: One or Two Entities?

  2021cites this paper
• Mechanisms of Psychiatric Comorbidities in Epilepsy.

  2021cites this paper
• The Applications of Deep Learning in Medical Imaging Diagnosis by Suryadipto Sarkar A Thesis Presented in Partial Fulfillment of the Requirements for the Degree Master of Science Approved June 2021 by the Graduate Supervisory Committee: Teresa Wu, Chair

  2021cites this paper
• Effect of Vortioxetine on Maximal electroshock (MES) induced seizures in Sprague Dawley rats

  2021cites this paper
• Applications, Advances, and Limitations of Molecular Imaging of Brain Receptors

  2021cites this paper
• Serotonin pretreatment abolishes sex-specific NMDA-induced seizure behavior in developing rats.

  2021cites this paper
• TACG_A_239478 61..76

  2021cites this paper
• Bidirectional Relations Among Depression, Migraine, and Epilepsy: Do They Have an Impact on Their Response to Treatment?

  2021cites this paper
• Cannabidiol Acts at 5-HT1A Receptors in the Human Brain: Relevance for Treating Temporal Lobe Epilepsy

  2020cites this paper
• PET in Epilepsy

  2020cites this paper
• Drug Treatment of Epilepsy Neuropsychiatric Comorbidities in Children

  2020cites this paper
• Sudden Unexpected Death in Epilepsy (SUDEP) — What Pediatricians Need to Know

  2020cites this paper
• Serotonin receptor imaging by 18F-PET

  2019cites this paper
• Imaging Comorbidities in Epilepsy: Depression

  2019cites this paper
• Serotonin and sudden unexpected death in epilepsy.

  2019cites this paper
• Intrahippocampal 5-HT1A receptor antagonist inhibits the improving effect of low-frequency stimulation on memory impairment in kindled rats.

  2019cites this paper
• Emotional asymmetries in refractory medial temporal and frontal lobe epilepsy: Their impact on predicting lateralization and localization of seizures.

  2019cites this paper
• Innovative Molecular Imaging for Clinical Research, Therapeutic Stratification, and Nosography in Neuroscience

  2019cites this paper
• Role of inflammation in epilepsy and neurobehavioral comorbidities: Implication for therapy.

  2018cites this paper
• Temporal lobe epilepsy-induced neurodegeneration and cognitive deficits: Implications for aging.

  2018cites this paper
• Effects of hypothyroidism on serotonin 1A receptors in the rat brain

  2018cites this paper
• Serotonin Reuptake Inhibitors in Obstructive Sleep Apnea: Associations in People with and without Epilepsy

  2018cites this paper
• Suicide in Children and Adults with Epilepsy: A Complex Relationship

  2018cites this paper
• Changes in functional coupling of 5-HT1A receptor to the G-protein in neocortex temporal tissues of patients with temporal lobe epilepsy

  2018cites this paper
• ALTERATIONS IN GABAERGIC NTS NEURON FUNCTION IN ASSOCIATION WITH TLE AND SUDEP

  2018cites this paper
• Serotonergic mechanisms in the 6-Hz psychomotor seizures in mice

  2018cites this paper
• Presurgical Focus Localization in Epilepsy: PET and SPECT.

  2017cites this paper
• Association Between Selective Serotonin-Reuptake Inhibitor Antidepressants and Increased Risk of Poststroke Epilepsy.

  2017cites this paper
• The receptor and transporter in temporal lobe

  2017cites this paper
• Can Neurochemical Changes of Mood Disorders Explain the Increase Risk of Epilepsy or its Worse Seizure Control?

  2017cites this paper
• Design, Synthesis and Evaluation of the Antidepressant and Anticonvulsant Activities of Triazole-Containing Benzo[d]oxazoles.

  2017cites this paper
• Assessing the role of serotonergic receptors in cannabidiol's anticonvulsant efficacy.

  2017cites this paper
• Sudden unexpected death in epilepsy

  2017cites this paper
• Contemplating stem cell therapy for epilepsy-induced neuropsychiatric symptoms

  2017cites this paper
• Neuroimaging of epilepsy.

  2016cites this paper
• The impact of epilepsy on the manifestation of anxiety disorder

  2016cites this paper
• Do traditional anti-seizure drugs have a future? A review of potential anti-seizure drugs in clinical development.

  2016cites this paper
• Common Mechanisms Underlying Epileptogenesis and the Comorbidities of Epilepsy.

  2016cites this paper
• Evidence in support of using a neurochemistry approach to identify therapy for both epilepsy and associated depression.

  2016cites this paper
• Antiepileptic drug use in a nursing home setting: a retrospective study in older adults.

  2016cites this paper
• Advances of Molecular Imaging in Epilepsy

  2016cites this paper
• Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: A review of the evidence.

  2016cites this paper
• Depression and anxiety in people with epilepsy: Why should we identify?

  2016cites this paper
• Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review

  2016cites this paper
• Serotonin receptor antagonists increase fast ripple activity in rats treated with kainic acid.

  2016cites this paper
• Nuclear Medicine Imaging in Epilepsy

  2015cites this paper
• Sudden Unexpected Death in Epilepsy : Mechanisms and New Methods for Analyzing Risks

  2015cites this paper
• Development of theta rhythm in hippocampal formation slices perfused with 5-HT1A antagonist, (S)WAY 100135.

  2015cites this paper
• Depression und Epilepsie

  2015cites this paper
• The relevance of neuropsychiatric symptoms and cognitive problems in new-onset epilepsy - Current knowledge and understanding.

  2015cites this paper
• PET studies in epilepsy.

  2015cites this paper
• Depression among school aged epileptic children and their siblings

  2015cites this paper
• Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII).

  2015cites this paper
• Drugs in Clinical Development

  2015cites this paper
• Depression and Anxiety in People with Epilepsy

  2014cites this paper
• Alterations of 5-HT1A receptor-induced G-protein functional activation and relationship to memory deficits in patients with pharmacoresistant temporal lobe epilepsy.

  2014cites this paper
• Biomarkers of Epileptogenesis: Psychiatric Comorbidities (?)

  2014cites this paper
• PET in Epilepsy

  2014cites this paper
• Do certain signal transduction mechanisms explain the comorbidity of epilepsy and mood disorders?

  2014cites this paper
• Is depression associated with an increased risk of treatment-resistant epilepsy? Research strategies to investigate this question.

  2014cites this paper
• A Bivariate Model Predicts Hemispheric Lateralization of the Seizure Onset Zone on Inter- Ictal [ 18 F]-FDG PET-CT Scans

  2014cites this paper
• Determination of optimal acquisition time of [(18)F]FCWAY PET for imaging serotonin 1A receptors in the healthy male subjects.

  2014cites this paper
• The role of different serotonin receptor subtypes in seizure susceptibility

  2014influential citation
• Functional imaging: PET.

  2013cites this paper
• What do we know about depression in people with epilepsy?

  2013cites this paper
• Combination Therapy of Piperine and Phenytoin in Maximal Electroshock Induced Seizures in Mice: Isobolographic and Biochemical Analysis

  2013cites this paper
• 5‐HT radioligands for human brain imaging with PET and SPECT

  2013cites this paper
• Current status of positron emission tomography radiotracers for serotonin receptors in humans.

  2013cites this paper
• IMAGE REGISTRATION USING COMPUTER TECHNIQUES: APPLICATIONS ON NUCLEAR MEDICINE IMAGES

  2013cites this paper
• The 5-HT1A receptor and 5-HT transporter in temporal lobe epilepsy

  2013cites this paper
• Rol del PET/CT en epilepsia

  2013cites this paper
• Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs?

  2013cites this paper
• Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression

  2013cites this paper
• Serotonin and Epilepsy: The Story Continues

  2013cites this paper
• 123I-ADAM SPET imaging of serotonin transporter in patients with epilepsy and comorbid depression

  2013cites this paper
• PET Imaging of the Serotoninergic 5-HT1A System

  2013cites this paper
• Stress, epilepsy, and psychiatric comorbidity: how can animal models inform the clinic?

  2013cites this paper